$0.7771
-0.11-12.21%
Last update: Nov 11, 4:17 AM
NeuroOne Medical Technologies Corp
NMTCNASDAQ
NeuroOne Medical Technologies fell 79.9% from $4.39 to $0.89, behind the S&P 500's +9.8%. Its worst day was Feb 17 (−16.5%), and its low came Oct 26 at $0.80.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.24 beat the $-0.24 estimate on $2.7M revenue (est. $2.5M).
−5.5% · S&P 500 −1.1%
NeuroOne Medical Technologies closed at its highest level of the year, 33.9% above where the year started.
Story events cover the past 12 months · Times ET
+15.5% · S&P 500 +0.6%
EPS of $-0.18 beat the $-0.24 estimate on $2.9M revenue (est. $2.7M).
−16.5%, the year's worst day · S&P 500 +0.2%
NeuroOne Medical Technologies shares rose 21.4%, while the S&P 500 fell 0.9%.
+21.4%, the year's best day · S&P 500 −0.9%
EPS of $-0.25 missed the $-0.23 estimate on $2.4M revenue (est. $2.6M).
+1.4% · S&P 500 −0.2%
EPS of $-0.28 missed the $-0.22 estimate on $2.0M revenue (est. $2.5M).
+20.4% · S&P 500 +0.7%
NeuroOne Medical Technologies shares fell 16.2%, while the S&P 500 fell 0.2%.
−16.2% · S&P 500 −0.2%
NeuroOne Medical Technologies closed at its lowest level of the year, 81.7% below where the year started.
−12.6% · S&P 500 +0.7%
Where it ended: a close of $0.89 on Nov 9, 2026. Up next: Q4 2026 earnings on Dec 16, 2026 (EPS est. $-0.19, revenue est. $3.8M).
Nothing in the past 12 months.
All NMTC dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NMTC and SPY from Benzinga historical bars. Not investment advice.
